CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) announced today that its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company’s quarterly results for the period ending June 30, 2008. The call will be held Thursday, August 7, 2008 at 4:05pm. EDT.
